文献速递主动脉疾病

体重指数与胸主动脉腔内修复术后结局的关联:血管质量倡议研究

Association of body mass index with outcomes after thoracic endovascular aortic repair in the vascular quality initiative.
PubMed 文献 · J Vasc Surg · 2021-09-06

本研究基于多机构国际数据库,回顾性分析2014年8月至2020年8月因降主动脉瘤或B型夹层行TEVAR的3423例患者,比较低体重、正常体重与肥胖患者的30天及1年死亡率。肥胖B型夹层患者30天死亡风险为正常体重者的2.67倍,但降主动脉瘤患者无差异;低体重患者1年死亡风险为正常体重者的2.15倍。

要点

  • 肥胖B型夹层患者TEVAR后30天死亡风险显著升高(OR 2.67)。
  • 肥胖降主动脉瘤患者TEVAR后30天及1年死亡风险与正常体重相当。
  • 低体重患者TEVAR后1年死亡风险为正常体重者的2.15倍。

核心结论

  • 肥胖降主动脉瘤患者TEVAR后30天和1年死亡风险与正常体重者相当。
  • 肥胖B型夹层患者TEVAR后30天死亡风险为正常体重者的2.67倍,但1年风险相当。
  • TEVAR是肥胖降主动脉瘤患者安全的微创治疗选择。

研究设计与样本

  • 回顾性多机构国际数据库研究,纳入2014年8月至2020年8月因降主动脉瘤或B型夹层行TEVAR的患者3423例。
  • 低体重(BMI<18.5 kg/m2)占3.3%(113例),正常体重(BMI≥18.5至<30 kg/m2)占65.9%(2253例),肥胖(BMI≥30 kg/m2)占30.8%(1053例)。
  • 采用多变量逻辑回归或Cox比例风险回归调整混杂因素,主要结局为30天和1年死亡率。

临床怎么用

  • 对肥胖降主动脉瘤患者,TEVAR可作为安全的微创治疗选项。
  • 对肥胖B型夹层患者行TEVAR时,应关注围手术期死亡风险并优化管理。
  • 对低体重TEVAR患者,需警惕1年远期死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although several studies have evaluated the impact of obesity on outcomes after abdominal aortic aneurysm repair, literature examining this association in thoracic endovascular aortic repair (TEVAR) is sparse. Here, we use a multi-institutional, international database to assess the role of body mass index (BMI) on adverse outcomes in patients who underwent TEVAR for descending thoracic aortic aneurysms (DTAA) and type B dissections (TBD). METHODS: A retrospective review of all patients who underwent TEVAR for DTAA or TBD from August 2014 to August 2020 was performed. Patients who were underweight (BMI <18.5 kg/m2) or obese (BMI ≥30 kg/m2) were compared with those of normal weight (≥18.5 to <30 kg/m2). Adjustment for confounding was done with multivariable logistic regression or Cox proportional hazards regression as appropriate for studying postoperative or 1-year outcomes. Primary outcomes were 30-day and 1-year mortality. Other outcomes included any postoperative complication, stroke, and spinal cord ischemia. RESULTS: A total of 3423 participants were included in the study, of whom 3.3% (n = 113) were underweight, 65.9% (n = 2253) had normal weight, and 30.8% (n = 1053) were obese. Compared with normal weight, there was no significant difference in 30-day mortality in underweight patients (odds ratio [OR], 1.81; 95% confidence interval [CI], 0.80-4.14; P = .156). Obese patients who underwent TEVAR for TBD had a 2.7-fold increase in the odds of 30-day mortality compared with normal weight (OR, 2.67; 95% CI, 1.52-4.68; P = .001). Obese and normal weight patients with DTAA had equivalent odds of 30-day mortality (OR, 1.32; 95% CI, 0.79-2.23; P = .292). The adjusted hazard of 1-year mortality was 2-fold higher in underweight patients compared with normal weight (hazard ratio, 2.15; 95% CI, 1.41-3.29; P < .001), driven by a higher risk of mortality among patients with thoracic aortic aneurysm (OR, 2.62; 95% CI, 1.63-4.21; P < .001). There was no significant difference in 1-year mortality risk between normal weight and obesity in both DTAA (OR, 0.77; 95% CI, 0.54-1.09; P = .146) and TBD (OR, 1.26; 95% CI, 0.85-1.86; P = .248). CONCLUSIONS: In this study, obese patients who underwent TEVAR for DTAA had comparable 30-day and 1-year mortality risk as normal weight individuals. Obese patients who underwent TEVAR for TBD demonstrated a 2.7-fold increase in the odds of 30-day mortality, but equivalent mortality risk as normal weight patients at 1 year. TEVAR represents a safe minimally invasive option for treatment of DTAA in obese patients. Future work should be directed toward minimizing perioperative mortality among patients with TBD to optimize TEVAR outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Naazie IN, Yei K, Osaghae I, et al. Association of body mass index with outcomes after thoracic endovascular aortic repair in the vascular quality initiative. J Vasc Surg. 2021. PMID: 34500030. doi:10.1016/j.jvs.2021.08.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。